| Differential Culturability of Mycobacterium tuberculosis in Culture-Negative Sputum of Patients With Pulmonary Tuberculosis and in a Simulated Model of Dormancy A Dusthackeer, M Balasubramanian, G Shanmugam, S Priya, CR Nirmal, ... Frontiers in microbiology 10, 2381, 2019 | 40 | 2019 |
| Formulation and evaluation of β-cyclodextrin-mediated inclusion complexes of isoniazid scaffolds: molecular docking and in vitro assessment of antitubercular properties L Tom, CR Nirmal, A Dusthackeer, B Magizhaveni, MRP Kurup New Journal of Chemistry 44 (11), 4467-4477, 2020 | 23 | 2020 |
| A multi-targeting pre-clinical candidate against drug-resistant tuberculosis P Kaur, V Potluri, VK Ahuja, CN Naveenkumar, RV Krishnamurthy, ... Tuberculosis 129, 102104, 2021 | 15 | 2021 |
| Inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis: In silico screening and in vitro validation CR Nirmal, R Rao, W Hopper European journal of medicinal chemistry 105, 182-193, 2015 | 14 | 2015 |
| Wild-Type MIC distribution for re-evaluating the critical concentration of anti-tb drugs and pharmacodynamics among tuberculosis patients from South India A Dusthackeer, SA Saadhali, M Thangam, S Hassan, M Balasubramanian, ... Frontiers in Microbiology 11, 1182, 2020 | 13 | 2020 |
| Anti-tuberculosis activity of bio-active compounds from Lantana camara L., Euphorbia hirta L., Mukia maderaspatana (L.) M. Roem, and Abutilon indicum (L.) CR Nirmal, RS Ebenezer, P Kannan, M Balasubramanian, ... European Journal of Integrative Medicine 35, 101105, 2020 | 13 | 2020 |
| Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofazimine P Saravanan, VNA Dusthackeer, RS Rajmani, B Mahizhaveni, CR Nirmal, ... Scientific Reports 11 (1), 1029, 2021 | 9 | 2021 |
| Myoinositol and methyl stearate increases rifampicin susceptibility among drug‐resistant Mycobacterium tuberculosis expressing Rv1819c CR Nirmal, SE Rajadas, M Balasubramanian, SK Mohanvel, MS Aathi, ... Chemical Biology & Drug Design 101 (4), 883-895, 2023 | 4 | 2023 |
| Determination of anti-tuberculosis activity of biosynthesized gold nanocompounds against M. tuberculosis H37RV MRK Priya, M Balasubramanian, CR Nirmal, A Dusthakeer, PR Iyer Indian Journal of Tuberculosis 70 (3), 329-338, 2023 | 3 | 2023 |
| Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c CR Nirmal, SE Rajadas, M Balasubramanian, D Magdaline, ... Indian Journal of Medical Research 157 (2&3), 192-203, 2023 | 1 | 2023 |
| Ofloxacin resistance in Mycobacterium tuberculosis: An increasing concern RS Kumar, KRU Devi, A Dusthackeer, CR Nirmal Indian Journal of Health Sciences and Biomedical Research kleu 14 (3), 302-309, 2021 | 1 | 2021 |
| Nanotheranostic management of drug-resistant tuberculosis VNA Dustachkeer, CR Nirmal, SE Rajadas, SA Saadhali, S Kannayan, ... A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy, 149-173, 2021 | 1 | 2021 |
